Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Insmed details new-hire equity inducement grants with defined vesting schedules and option terms under its 2025 Inducement Plan.

Rhea-AI Summary

Insmed (INSM) granted equity inducement awards to 128 new employees under its 2025 Inducement Plan, designed to comply with Nasdaq Listing Rule 5635(c)(4).

Effective August 31, 2026, the employees received a total of 115,320 restricted stock units and options to purchase an aggregate 5,560 shares of Insmed common stock at an exercise price of $121.82 per share, equal to the closing trading price on the grant date. The restricted stock units vest over four years in equal 25% annual installments, starting on the first anniversary of the first day of the month following the grant date, subject to continued service.

The stock options have a 10-year term and a four-year vesting schedule, with 25% vesting on the first such anniversary and 12.5% vesting every six months thereafter through the fourth anniversary, also contingent on continued employment.

News Explained

For existing common holders, the awards create a potential future increase in shares outstanding: 115,320 restricted stock units can deliver shares as employees remain in service, while options for 5,560 shares require exercise; the release reports grants, not completed share issuance.

Argus Sep 4 session

-0.31% close to close Open Argus

Details

News Market Reaction – INSM

On Sep 4, the day this news came out, INSM closed 0.31% below the previous close.

Data tracked by StockTitan Argus for the Sep 4 session.

Key Figures

New employees: 128 employees Restricted stock units: 115,320 restricted stock units Option shares: 5,560 shares +3 more

New employees

128 employees

Inducement awards

Restricted stock units

115,320 restricted stock units

Awards granted on August 31, 2026

Option shares

5,560 shares

Aggregate shares subject to options

Exercise price

$121.82 per share

Closing trading price on the grant date

RSU vesting

Four-year vesting schedule

25% vests on each anniversary

Option term

10-year term

Employee stock options

Historical Context

5 past events · Latest: Sep 03

5 events

1. Sep 03

   respiratory data presentation

   24h Move

   +0.0%

   Planned presentation of five respiratory portfolio abstracts at ERS Congress 2026

2. Aug 26

   investor conference presentations

   24h Move

   +0.4%

   Management scheduled presentations at two September healthcare investor conferences

3. Aug 24

   Japan regulatory approval

   24h Move

   -1.4%

   Japan approved BRINSUPRI for adults and pediatric patients with NCFB

4. Aug 06

   second-quarter earnings

   24h Move

   +33.9%

   Revenue growth and raised BRINSUPRI guidance drove the quarterly update

5. Jul 23

   earnings call scheduling

   24h Move

   +0.7%

   Company scheduled its second-quarter financial results release and conference call

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

inducement awards, restricted stock units, vesting schedule, nasdaq listing rule 5635(c)(4)

4 terms

inducement awards regulatory

"today announced the granting of inducement awards to 128 new employees."

Inducement awards are special bonuses given to new employees to encourage them to join a company, often in the form of stock or money. They matter because they can motivate talented people to choose one company over another and help align their success with the company's growth. Think of it like a signing bonus to seal the deal.

restricted stock units financial

"the employees received 115,320 restricted stock units and options"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

vesting schedule financial

"The restricted stock units have a four-year vesting schedule"

A vesting schedule is a timeline that determines when someone gains full ownership of certain benefits, such as company stock or retirement contributions. Think of it like earning the right to own a gift gradually over time, rather than receiving it all at once. It matters to investors because it affects when they can fully access or sell these benefits, influencing their financial planning and decision-making.

nasdaq listing rule 5635(c)(4) regulatory

"under Nasdaq Listing Rule 5635(c)(4)."

NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BRIDGEWATER, N.J., Sept. 4, 2026 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, today announced the granting of inducement awards to 128 new employees. The awards were granted under the Insmed Incorporated 2025 Inducement Plan, which is intended to meet the requirements of a plan providing for inducement grants under Nasdaq Listing Rule 5635(c)(4). The awards were approved by Insmed's Compensation Committee and made as a material inducement to each employee's entry into employment with the Company.

In connection with the commencement of their employment, on August 31, 2026, the employees received 115,320 restricted stock units and options to purchase an aggregate 5,560 shares of Insmed common stock at an exercise price of $121.82 per share, the closing trading price on the Nasdaq Global Select Market on the date of grant.

The restricted stock units have a four-year vesting schedule, with 25% of the shares underlying each restricted stock unit grant vesting on each anniversary of the first day of the month immediately following the grant date, subject to the relevant employee's continued service with Insmed on the applicable vesting date.

The options have a 10-year term and a four-year vesting schedule, with 25% of the shares subject to the option vesting on the first anniversary of the first day of the month immediately following the grant date and 12.5% of the shares subject to the option vesting every six months thereafter through the fourth anniversary thereof, subject to the relevant employee's continued service with Insmed on the applicable vesting date.

About Insmed

Insmed Incorporated is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. The Company is advancing a diverse portfolio of approved and mid- to late-stage investigational medicines — including two approved therapies to treat chronic, debilitating lung diseases — as well as cutting-edge drug discovery focused on serving patient communities where the need is greatest. Insmed's commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology & Inflammation, and Neuro & Other Rare. The Company's research engine is advancing a wide range of technologies and modalities, including gene therapy, AI-driven protein engineering, RNA end-joining, and synthetic rescue, in the pursuit of future pipeline candidates.

Headquartered in Bridgewater, New Jersey, Insmed has offices and research locations throughout the United States, Europe, and Japan. Insmed is proud to be recognized as one of the best employers in the biopharmaceutical industry, including spending five consecutive years as the No. 1 Science Top Employer. Visit www.insmed.com to learn more or follow us on LinkedIn, Instagram, YouTube, and X.

Contact:

Investors:

Sara Bonstein
Chief Financial Officer
investor.relations@insmed.com

Media:

Claire Mulhearn
Vice President, Corporate Communications
media@insmed.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-302869247.html

SOURCE Insmed Incorporated

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What inducement equity grants did Insmed (INSM) announce for new employees?

Insmed announced equity inducement grants for 128 new employees under its 2025 Inducement Plan. The grants include 115,320 restricted stock units and options to purchase an aggregate 5,560 shares of Insmed common stock, issued as a material inducement to join the company.

What is the exercise price and term of the new Insmed (INSM) stock options?

The inducement stock options have an exercise price of $121.82 per share, which matches the closing trading price on the grant date of August 31, 2026. These options carry a 10-year term, during which they may be exercised subject to vesting and continued employment.

How do the restricted stock units granted by Insmed (INSM) vest for new hires?

The 115,320 restricted stock units granted to new Insmed employees vest over four years. 25% of the shares underlying each RSU grant vest on each anniversary of the first day of the month immediately following the grant date, subject to the employee’s continued service.

What is the vesting schedule for the new Insmed (INSM) stock options?

The new stock options vest over four years. 25% of the shares subject to each option vest on the first anniversary of the first day of the month following the grant date, and 12.5% vest every six months thereafter through the fourth anniversary, contingent on continued employment.

Why were the Insmed (INSM) inducement grants made under Nasdaq Listing Rule 5635(c)(4)?

The grants were issued under the 2025 Inducement Plan, which is intended to satisfy Nasdaq Listing Rule 5635(c)(4) requirements. Insmed states that the awards were a material inducement to each employee’s entry into employment with the company, allowing equity grants without prior shareholder approval.